Klaus Hinterding

USPTO Granted Patents = 12 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 2)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 53(Granted Patents)

Location History:

Ruemmingen, DE (2007)
Rümmingen, DE (2008)
Basel, CH (2012)
Wittlingen, DE (2009 - 2013)

Company Filing History:

Years Active: 2007-2013

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8431589 - 2,4-diaminopyrimidine derivatives (2013-04-30),

2. 8283356 - 2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors (2012-10-09),

3. 7943627 - 2,4-diaminopyrimidine derivatives (2011-05-17),

4. 7928093 - Amino-propanol derivatives (2011-04-19),

5. 7825260 - Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators (2010-11-02),

6. 7728020 - Amino acid derivatives (2010-06-01),

7. 7696184 - Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator (2010-04-13),

8. 7671063 - 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors (2010-03-02),

9. 7625950 - Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator (2009-12-01),

10. 7612238 - Amino-propanol derivatives (2009-11-03),

11. 7326801 - 2-amino-propanol derivatives (2008-02-05),

12. 7169817 - Bis-aromatic alkanols (2007-01-30),

Certainly! Here is the article about inventor Klaus Hinterding:

Title: The Innovative Mind of Klaus Hinterding

Introduction: Klaus Hinterding, a distinguished inventor hailing from Wittlingen, Germany, has made significant contributions to the field of pharmaceuticals with a total of 12 patents to his name.

Latest Patents: Among his latest creations are 2,4-diaminopyrimidine derivatives, which are compounds known for their utility in disorders related to ZAP-70 and/or Syk inhibition. Additionally, he has introduced 2,4-Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors, showcasing his expertise in developing compounds with valuable pharmaceutical properties.

Career Highlights: Klaus Hinterding has wielded his inventive prowess at esteemed companies such as Novartis AG and Irm LLC, where he has honed his skills and brought forth groundbreaking patents that have the potential to revolutionize the pharmaceutical industry.

Collaborations: Throughout his career, Klaus has collaborated with industry experts such as Rolf Baenteli and Nigel Graham Cooke, leveraging their collective knowledge and experience to fuel the creation of innovative solutions to complex medical challenges.

Conclusion: In conclusion, Klaus Hinterding stands as a beacon of innovation in the pharmaceutical realm, with an impressive portfolio of patents and a track record of successful collaborations that underscore his commitment to advancing healthcare through cutting-edge inventions.

I hope this article provides you with valuable insight into the inventive legacy of Klaus Hinterding. If you have any further questions or need additional information, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

8 patents (EPO):

Please report any incorrect information to support@idiyas.com

2 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.